Regulatoriskt pressmeddelande

Invitation to Swedencare AB (publ) Q1 2026 interim report presentation

The 23rd of April at 7:30am CEST Swedencare AB (publ) will publish the interim report of Q1 2026. A presentation of the report will be held the same day at 10:30am CEST via live webinar. The presentation will be available on the website at 9:30am CEST.

Swedencare invites shareholders and analysts to a presentation of the Q1 report where CEO Håkan Lagerberg and CFO Jenny Graflind will comment on the report. The presentation will be held at 10:30-11:30am CEST and can be followed via live webinar. Laszlo Varga, CCO of Europe will also take part in the presentation. The report will be published at 7:30am CEST and will be available at www.swedencare.com.

The presentation will be held in English and after the presentation questions can be asked live via the webinar. No registration is needed.

Please use this link to join the webinar: https://us06web.zoom.us/j/89020244666
After the presentation a recorded version will be available on our webpage.

About Swedencare

Swedencare is listed on the NASDAQ First North Growth Market and also trades on the OTCQX® Best Market. We develop, produce, and sell premium products in the global and rapidly growing pet healthcare market, focusing on cats, dogs, and horses. Our extensive product portfolio includes strong brands such as NaturVet®, Innovet, Pet MD®, Rx Vitamins®, nutravet®, Rileys®, and ProDen PlaqueOff®, the original solution for good oral health.

With headquarters in Malmö, our products are sold in approximately 70 countries through online channels, pet stores, veterinarians, and FDMC. Our extensive distribution network consists of subsidiaries in nine countries, along with an international network of retailers. Swedencare has experienced strong growth for several years while maintaining high profitability.